Toxogen GmbH
Records under this name other than the patents Toxogen GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Toxogen GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,293,230 | Transport protein which is used to introduce chemical compounds into nerve cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,481,040 | Carrier for targeting nerve cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,115,350 | Carrier for targeting nerve cells Formerly held Term ended Ended no later than Apr 26, 2026 · From the USPTO record | Term ended | Ended no later than Apr 26, 2026 | From the USPTO record |
| US 9,650,622 | Carrier for targeting nerve cells Formerly held Term ended Ended no later than Apr 26, 2026 · From the USPTO record | Term ended | Ended no later than Apr 26, 2026 | From the USPTO record |
| US 10,266,816 | Carrier for targeting nerve cells Formerly held Term ended Term ended Apr 26, 2026 · From the USPTO record | Term ended | Term ended Apr 26, 2026 | From the USPTO record |
| US 10,883,096 | Carrier for targeting nerve cells Formerly held Term ended Term ended Apr 26, 2026 · From the USPTO record | Term ended | Term ended Apr 26, 2026 | From the USPTO record |
| US 9,234,011 | Transport protein which is used to introduce chemical compounds into nerve cells Term ended Term ended Dec 30, 2025 · From the USPTO record | Term ended | Term ended Dec 30, 2025 | From the USPTO record |
| US 9,422,344 | Transport protein which is used to introduce chemical compounds into nerve cells Formerly held Term ended Term ended Sep 6, 2025 · From the USPTO record | Term ended | Term ended Sep 6, 2025 | From the USPTO record |